Gastrointestinal infection test kit GI

leadrotavirusadenovirus

With overlapping symptoms, distinguishing possible causes of gastroenteritis can be challenging for any clinician. To further complicate diagnosis, traditional testing methods are slow, labor intensive, and fail to reveal the etiology of a patient’s gastrointestinal symptoms.1 Fortunately, syndromic testing from the BioFire GI Panel eliminates limitations from conventional methods by providing, faster, more accurate, and comprehensive results. 22 Targets. 1 Test. The FDA-cleared BioFire GI Panel tests for 22 of the most common pathogens associated with gastroenteritis—all from one patient sample and one easy to use reagent, with results available in about one hour. A New Option for C. difficile Reporting A new pouch module option called C. difficile Select* gives users running the BioFire GI Panel on either the BioFire® FilmArray® Torch or the BioFire® FilmArray® 2.0 System the choice to either always report or never report C. difficile results. Clinical Benefits Because traditional stool testing methods are slow and lack sensitivity, clinicians often have to make patient management decisions without a laboratory result. Syndromic testing from the BioFire GI Panel offers fast sample-to-answer turnaround and accurate results, which can: Reduce antibiotic use3 Reduce time to antimicrobial therapy4 Lead to more targeted therapy4 Reduce downstream procedures such as endoscopies and abdominal imaging3